Jonathan M. Sedgh is a product liability attorney who, over the course of more than a decade practicing law, has played an instrumental role in various lawsuits against the makers of dangerous and defective pharmaceuticals, medical devices, and implants. He has also helped survivors of sex trafficking and childhood sexual abuse pursue justice against their perpetrators.
A native New Yorker, Mr. Sedgh is a graduate of Hofstra University School of Law on Long Island. There he earned a juris doctor degree, as well as a bachelor of business administration.
Mr. Sedgh’s career took off swiftly. At his previous law firm, he was a key figure in more than a dozen multi-district litigations and state-court coordinated actions where he managed and litigated thousands of cases from inception to settlement or trial.
Notably, in 2014, Mr. Sedgh recovered a $9 billion verdict in a multi-district trial for a client who developed bladder cancer after taking Actos, an anti-diabetic medication. The drug, manufactured by Takeda and marketed in the U.S. by Eli Lilly, had been linked to an increased risk for the condition. The suit alleged that the two companies continued to manufacture and market the drug despite knowing of its dangers, and that they failed to inform the medical community. The verdict, delivered by a jury of eight, is one of the largest jury awards in history.
In light of his achievements, Mr. Sedgh was named a top Rated Products Liability Attorney in New York City and a Rising Star by Super Lawyers magazine. The National Trial Lawyers – an association promoting excellence in the legal profession – designated him as a Top 40 Under 40 trial attorney.
Over the years, Mr. Sedgh has been both a speaker and panelist at mass-tort product liability seminars around the United States. He is a member of the bar associations of New York State and New York City. In 2011, the New York City bar association hand-selected him as one of 25 attorneys to serve on its product liability committee, an exclusive group that includes the in-house counsel of major pharmaceutical and medical device companies.